State of Wyoming’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-304
Closed -$8.22K – 2181
2026
Q1
$8.22K Sell
304
-117
-28% -$3.93K ﹤0.01% 1729
2025
Q4
$18K Buy
+421
New +$15.9K ﹤0.01% 1698
2024
Q3
– Sell
-11,029
Closed -$90.7K – 1867
2024
Q2
$90.7K Buy
11,029
+2,097
+23% +$21.9K 0.01% 1068
2024
Q1
$132K Sell
8,932
-2,300
-20% -$31K 0.02% 835
2023
Q4
$163K Buy
11,232
+2,613
+30% +$26.7K 0.03% 699
2023
Q3
$93.1K Buy
8,619
+2,073
+32% +$24.9K 0.02% 906
2023
Q2
$84.4K Buy
6,546
+4,700
+255% +$63.5K 0.02% 927
2023
Q1
$24.4K Sell
1,846
-370
-17% -$5.88K 0.01% 1375
2022
Q4
$33.2K Buy
+2,216
New +$20.3K 0.01% 1187
2022
Q3
– Sell
-798
Closed -$9K – 1870
2022
Q2
$9K Sell
798
-245
-23% -$4.92K 0.01% 1661
2022
Q1
$31K Buy
1,043
+144
+16% +$3.9K 0.02% 1302
2021
Q4
$24K Buy
899
+500
+125% +$15.1K 0.01% 1426
2021
Q3
$14K Buy
399
+224
+128% +$8.82K 0.01% 986
2021
Q2
$8K Buy
+175
New +$6.61K 0.01% 1039

Other funds holding RIGL

State of Wyoming's RIGL Position: Q2 2026 in Review

State of Wyoming sold out of Rigel Pharmaceuticals (RIGL) in Q2 2026, closing a stake of 304 shares — an estimated $8.22K sold.

State of Wyoming first reported a position in RIGL in Q2 2021 and held it in 14 quarters. The position peaked at $163K in Q4 2023. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • State of Wyoming reported no remaining Rigel Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • State of Wyoming sold 304 Rigel Pharmaceuticals shares in Q2 2026, an estimated $8.22K.
  • State of Wyoming first reported a position in Rigel Pharmaceuticals in Q2 2021 and held it in 14 quarters.
  • State of Wyoming's Rigel Pharmaceuticals position peaked at $163K in Q4 2023.
  • 155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.